Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-09

FDA Approved: LOPERAMIDE HYDROCHLORIDE — Supplemental Application (Chain Drug Marketing Association Inc.)

View source ↗

Summary

FDA approved a supplemental application for loperamide hydrochloride (generic), submitted by Chain Drug Marketing Association Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loperamide hydrochloride (LOPERAMIDE HYDROCHLORIDE)

Snippet

SUPPL AP for LOPERAMIDE HYDROCHLORIDE (LOPERAMIDE HYDROCHLORIDE)